Highmark Health has appointed Karen Hanlon chief executive officer and president, effective Jan. 1, 2027. David Holmberg, who has served as CEO since 2014, will become executive chairman.
The Pittsburgh-based organization said the board made the appointments as part of a leadership transition. Hanlon, currently its president, will be the first female CEO in Highmark Health’s history.
In her new role, Hanlon will lead strategy, operations, growth and performance across Highmark Health’s health plans, Allegheny Health Network (AHN) and diversified businesses. The company said she has worked there for nearly three decades.
During that time, the organization expanded from approximately $17 billion in revenue in 2014 to nearly $35 billion projected at year end. The figures describe the enterprise’s growth during Hanlon’s tenure, according to the announcement.
Hanlon joined Highmark in 1997 after beginning her career in public accounting at KPMG. She held several finance leadership roles before becoming chief financial officer in 2014. She was named chief operating officer in 2018 and president in 2025.
Hanlon’s Path to the Top Role
Highmark Health credited Hanlon with helping expand its health-plan affiliations into five additional states. The company cited recent integrations with New York-based Health Now and Kansas City-based Blue KC.
It also said Hanlon led the acquisition and transition of Gateway Health to Highmark Wholecare, adding Medicaid products to the health-plan portfolio. She was involved in the formation and development of AHN, including leading its first $1 billion tax-exempt bond financing to stabilize its long-term capital structure and support system growth.
Highmark Health board chair Greg Jordan said the board has confidence in Hanlon’s ability to lead the organization and advance its Living Health strategy. Jordan also thanked Holmberg for his leadership and said he would continue supporting the organization as executive chairman.
Holmberg will work with Hanlon and the board to support what the company described as a smooth transition and advance its long-term strategic priorities. His next role keeps him involved in the organization after more than 12 years as CEO.
Leadership Transition and Strategy
Hanlon said the organization would continue working toward making healthcare more affordable, simpler and more effective. She also cited its Living Health strategy and goal of delivering health experiences for the people and communities it serves.
Holmberg described Hanlon as a leader with operational expertise and said she had earned the trust of employees and stakeholders. His comments were part of the company’s announcement, which framed the appointment as a continuation of its growth and transformation.
Highmark Health said it employs more than 47,000 people and serves millions of Americans. The parent company includes Highmark, AHN and enGen. Its leadership transition also joins a broader set of business stories about executive responsibilities, including changing leadership demands, a board leadership appointment and a health company strategy.
The appointment takes effect Jan. 1, 2027, when Hanlon assumes the CEO and president roles and Holmberg begins serving as executive chairman. The company said the transition is intended to support its strategy and long-term priorities.
Read the leadership announcement for the company’s full statement.
